FORMULATION AND OPTIMIZATION OF ITRACONAZOLE PRONIOSOMES USING BOX BEHNKEN DESIGN


Ahmed M. Samy, Afaf A. Ramadan, Amal S.m. Abu El-enin, Yasmin I. M. Mortagi

Abstract


Objective: The aim of the present study was to obtain an optimized formula of itraconazole (ITC) proniosomes using Box Behnken design.

Methods: Itraconazole proniosomes were preparedusing span 60 and/or brij 35 as surfactants, cholesterol and lecithin as a penetration enhancer by slurry method. Various trials have been carried out for investigation of proniosomes. Parameters such as entrapment efficiency (EE%), in vitro drug release, zeta potential, vesicle size and Transmission Electron Microscope were assessed for evaluation of proniosomes.

Results: Entrapment efficiency (EE%) was found to be between 78.56% and 95.46%. The release profile of itraconazole proniosomes occurred in two distinct phases, an initial phase for about 8 h, followed by slow phase for 16 h. The release pattern shown by these formulations was Higuchi diffusion controlled mechanism. The zeta potential values for all itraconazole proniosomes were in the range of -21.71 to -34.53 mV which confirms their stability. All itraconazoleproniosomes formula were found to be nano-sized and were appeared to be spherical in shape with sharp boundaries. One way analysis of variance (ANOVA) study showed that HLB (X1) had the main effects on most responses (Y).

Conclusion: Box behnken design facilitates optimization of the formulation ingredients on entrapment efficiency, in vitro release of itraconazole proniosomes, zeta potential and vesicle size. Finally, an optimum level of factors was provided by the optimization process.


Keywords


Box behnken design, proniosomes, entrapment efficiency (EE%), Itraconazole (ITC), optimization.

References


Cheriyan P, George BJ, Thomas N, Raj P, Samuel J, Carla SrB, Formulation and characterization of maltodextrin based proniosomes of cephalosporins. World J Pharm Sci 2015;3: 62-74.

El-Ridy MS, Bawai AA, Safar MM, Mohsen AM, Niosomes as a novel pharmaceutical formulation encapsulating the hepatoprotective drug silymarin. Int J Pharm PharmSci 2012;4: 549-59.

Naggar VF, Elgamal SS, Allam AN, Proniosomes as a stable carrier for oral acyclovir: Formulation and physicochemical characterization. J AmSci 2012;8: 417-28.

Sammour OA, Improvement of encapsulation efficiency of timolol maleate in liposome by the freeze-thawing method. Zag J pharm Sci 1992;1: 34-42.

Tang J, Wei H, Liu H, Ji H, Dong D, Zhu D et al., Pharmacokinetics and biodistribution of itraconazole in rats and mice following intravenous administration in a novel liposome formulation, Drug Deliv2010; 17: 223-30.

Gareth A. Encyclopedia of pharmaceutical technology. 2nd ed. Marcel Dekker [NY]; 2002.

Tank CJ, Bokhataria C, Baria AH, Formulation and evaluation of aceclofenac loadedmaltodextrin based proniosomes. Int JChemTech Res 2009;1: 567-73.

Sampathi S,Mankala SK,WankarJ,Dodoala, Nanoemulsion based hydrogels of itraconazole for transdermal drug delivery. J SciInd Res 2015;74: 88-92.

Asija R, Sharma D, Nirmal H, Development of proniosomal gel as a drug carrier for transdermal delivery of Acyclovir. J Drug Disc Ther2014; 2: 41-51.

Thomas L, Viswanad V, Formulation and optimization of clotrimazole-loaded proniosomal gel using 32 factorial design. Sci Pharm 2012;80: 731-48.

Box GE, Hunter WG, Hunter JS, Statistics for experiments: design with more than one blocking variable. 2nd ed. [NY]: Wiley Publisher;1978.

Uchegbu IF, Florence AT, Non-ionic surfactant vesicles (niosomes) physical and pharmaceutical chemistry. Adv Colloid Interface Sci 1995;58: 1-55.

Badawi A, El Nabarawi MA, Elrehem RT, Fayed BA, Formulation and evaluation of dispersed permethrinproniosomes in powder and microemulsion-based hydrogel bases for the treatment of scabies. Int J Pharm PharmSci2016 ;8: 221-29.

Alsarra IA, Evaluation of proniosomes as an alternative strategy to optimizepiroxicam transdermal delivery. J microencapsulation 2008;1: 1-7.

Benipal G, Design development and evaluation of proniosomal gel of an antifungal drug ketoconazole. Int J Pharm Sci Rev Res 2015;31: 265-72.

AcharyaA,KumarKGB,Ahmed MG, Paudel S,A Novel approach to increase the bioavailability of candesartan cilexetil by proniosomal gel formulation: in-vitro and in-vivo evaluation. Int J Pharm PharmSci 2016;8: 241-46.

Pardakhty A, Varshosaz J, Rouholamini A, In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 2007;328: 130-41.

Abdelbary GA, Amin MM, Zakaria MY, Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv 2017;24: 309–19.

Kumar BS, Krishna R, Lakshmi PS, Vasudev DT, Nair SC, Formulation and evaluation of niosomal suspension of cefixime. Asian J Pharm Clin Res 2017;10: 194-201.

Pankaj S, Rini T, Dandagi PM, Formuation and evaluation of proniosome based drug delivery system of the antifungal drug clotrimazole. Int J Pharm Sci Nanotech 2013;6: 1945-51.

Arafa MG, Ayoub BM, Nano-vesicles of salbutamol sulphate in metered dose inhalers: formulation, characterization and in vitro evaluation. Int J App Pharm 2017;9: 100-5.

Singla S, Harikumar SL, Aggarwal G, Proniosomes for penetration enhancement in transdermal system. Int J Drug Dev& Res 2012;4: 1-13.

Kamboj S, Saini V, Bala S, Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. Scientific World J 2014;2014: 1-8.

Okare VC, Attama AA, Ofokansi KC, Esimone CO, Onuigbo EB, Formulation and evaluation of niosomes. Ind J Pharm Sci2011;73: 323-28.

Chauhan MK, Sahoo PK, Rawat AS, DuggaL D, Kandwal M, Nidhi S, Formulation, characterization and in vitro evaluation of tactically engineered proniosomes for successful oral delivery of ramipril. Der Pharmacia Lettre2015; 7: 93-7.

Balakrishnan P, Shanmugam S, Lee WM, Kim JO, Oh DH, Kim DD et al., Formulation and in vitro assessment of minoxidilniosomes for enhanced skin delivery. Int J Pharm 2009;10: 1004-20.

Desai S, Doke A, Disouza J, Athawale R, Deveopment and evaluation of antifungal topical niosomal gel formulation. Int J Pharm PharmSci 2011;3: 224-31.

Ola AMM, El-Ashmoony MM, Elgazayerly ON, Niosome-encapsulated clomipramine for transdermal controlled delivery. Int J Pharm PharmSci 2014;6: 567-75.

Mishra A, Kapoor A, Bhargava, Proniosomal gel as a carrier for transdermal drug delivery of clotrimazole. Int J Pharm PharmSci 2012;4Suppl 4:610-14.

Das MK, Palei NN, Sorbitan ester niosomes for topical delivery of rofecoxib. Ind J ExpBiol2011;49: 438-45.




Fatal error: Call to a member function getGalleyLabel() on null in /home/innowar1/public_html/journals/cache/t_compile/%%38^38D^38D7420B%%article.tpl.php on line 189